Kevin is responsible for identifying early stage targets, small molecules and monoclonal antibodies for our drug discovery group and the licensing of mature programmes to industry.
![A portrait of Kevin Buchan.](https://www.lifearc.org/wp-content/uploads/2017/03/Kevin-Buchan-new-headshot-1.png)
Kevin Buchan
Latest news
-
New smartphone app offers hope in the fight against neglected tropical diseases
Read more: New smartphone app offers hope in the fight against neglected tropical diseases -
Bronchiectasis: an overlooked lung condition with untapped commercial and research potential
Read more: Bronchiectasis: an overlooked lung condition with untapped commercial and research potential -
Cambridge Science Centre opens new facility that will educate and inspire the next generation of scientists
Read more: Cambridge Science Centre opens new facility that will educate and inspire the next generation of scientists